Boltendahl International Partners

Boltendahl International Partners has established itself as a distinguished M&A boutique focusing on mid-market transactions over its 15-year tenure in the financial advisory space. With a global operational footprint, the firm has successfully facilitated numerous cross-border deals, leveraging its extensive network of industry contacts and specialized expertise. Their boutique structure allows for personalized attention to clients while maintaining the sophisticated capabilities necessary for complex international transactions.

The firm has developed deep sector expertise across the healthcare ecosystem, including Life Sciences, Pharmaceuticals, Biotech, and Medical Devices. Additionally, Boltendahl maintains specialized knowledge in Animal Health, Food Supplements, and Technology, Media & Telecommunications (TMT) sectors. This industry focus enables their advisory team to provide nuanced insights into market trends, regulatory considerations, and strategic opportunities specific to these high-growth, innovation-driven industries.

Boltendahl offers a comprehensive suite of financial advisory services tailored to mid-sized enterprises and investors. Their core capabilities encompass both buy-side and sell-side M&A origination, facilitating Private Equity investments, and structuring early-stage financing rounds for promising ventures. The firm has developed particular expertise in Venture Capital projects, where they guide emerging companies through critical growth phases while connecting them with appropriate capital sources. Their transaction support extends through negotiation and closing phases, ensuring deals progress efficiently to completion.

Beyond traditional M&A services, Boltendahl provides strategic advisory in equity expansion strategies, helping clients optimize their capital structure and funding approaches. Their analytical capabilities include sophisticated business plan development, company valuations, and fairness opinions that meet international standards. As a privately owned advisory firm, Boltendahl maintains independence in its recommendations, allowing for objective guidance aligned with client objectives rather than external shareholder interests. This client-centric approach has contributed to their strong reputation for transaction execution excellence in specialized mid-market segments.